4-cyclohexyl-3-thiophen-2-yl-1H-1,2,4-triazole-5-thione | 724701-83-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: 4-cyclohexyl-3-thiophen-2-yl-1H-1,2,4-triazole-5-thione
• CAS: 724701-83-1
• 化学式: C₁₂H₁₅N₃S₂
• mdl: MFCD07774561
• 分子量: 265.403
• InChiKey: AOXGLLSRMBLBSO-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.5
• 重原子数：
  17
• 可旋转键数：
  2
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  88
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  N-cyclohexyl-2-(thiophene-2-carbonyl)hydrazinecarbothioamide 在 sodium hydroxide 作用下， 以 水 为溶剂， 反应 2.0h， 以89%的产率得到4-cyclohexyl-3-thiophen-2-yl-1H-1,2,4-triazole-5-thione
  参考文献：
  名称：

  Chemical and Pharmacological Properties of 3-(Thiophen-2-yl)-4-substituted-Δ²-1,2,4-triazoline-5-thiones

  摘要：

  Three 3-(thiophen-2-yl)-4-substituted-Delta(2)-1,2,4-triazoline-5-thiones were synthesized by intramolecular cyclization of 1-(thiophen-2-ylcarbonyl)-4-substituted thiosemicarbazides in alkaline medium. Their effects on the central nervous system (CNS) of mice in some behavioral tests were investigated. All investigated compounds displayed antinociceptive activity. The correlation between the structural features and bioactivity has been discussed.

  DOI：

  10.1080/10426500801968136

文献信息

• Dibenzocycloheptene compound
  申请人：——

  公开号：US20040180884A1

  公开（公告）日：2004-09-16

  The present invention discloses a dibenzocycloheptene compound represented by the formula (I): 1 wherein R 1 : hydrogen atom, halogen atom, etc., R 2 hydrogen atom, halogen atom, etc., A: 5-membered or 6-membered heteroaromatic ring group containing 1 to 3 hetero atom(s) selected from the group consisting of nitrogen atom, oxygen atom and sulfur atom, and the heteroaromatic ring group, etc. may have halogen atom, nitrogen atom, etc. as substituent(s),.B: formula; —CH═CH—, formula; —CH 2 O—, etc., Y: C 1 -C 10 alkylene group which may have halogen atom, etc. as substituent(s), etc., Z: carboxyl group which may be protected, etc., m: an integer of 1 to 4, n: an integer of 1 to 3, represents a single bond or a double bond, or a pharmaceutically acceptable salt thereof and a medical composition containing the same as an effective ingredient which has leukotriene C 4 antagonistic action and leukotriene E 4 antagonistic action in addition to potent leukotriene D 4 antagonistic action, and useful as antiasthmatic agent, antiallergic agent and anti-inflammatory agent.

  本发明揭示了一种由式(I)表示的二苯并环庚烯化合物：1其中，R1：氢原子、卤素原子等；R2：氢原子、卤素原子等；A：5-或6-成员的杂芳环基团，包含从氮原子、氧原子和硫原子组成的1至3个杂原子，所述杂芳环基团等可以具有卤素原子、氮原子等作为取代基；B：式；-CH═CH-，式；-CH2O-等；Y：C1-C10烷基，可以具有卤素原子等作为取代基；Z：羧基，可以被保护等；m：1至4的整数，n：1至3的整数；表示单键或双键，或其药学上可接受的盐，以及含有其作为有效成分的医药组合物，具有白三烯C4拮抗作用和白三烯E4拮抗作用，除了强大的白三烯D4拮抗作用外，还可作为抗哮喘剂、抗过敏剂和抗炎剂。
• DIBENZOCYCLOHEPTENE COMPOUND
  申请人：Ube Industries, Ltd.

  公开号：EP1408033A1

  公开（公告）日：2004-04-14

  The present invention discloses a dibenzocycloheptene compound represented by the formula (I):    wherein R1: hydrogen atom, halogen atom, etc., R2: hydrogen atom, halogen atom, etc., A: 5-membered or 6-membered heteroaromatic ring group containing 1 to 3 hetero atom(s) selected from the group consisting of nitrogen atom, oxygen atom and sulfur atom, and the heteroaromatic ring group, etc. may have halogen atom, nitrogen atom, etc. as substituent(s), B: formula; -CH=CH-, formula; -CH2O-, etc., Y: C1-C10 alkylene group which may have halogen atom, etc. as substituent(s), etc., Z: carboxyl group which may be protected, etc., m: an integer of 1 to 4, n: an integer of 1 to 3,    ------ represents a single bond or a double bond, or a pharmaceutically acceptable salt thereof and a medical composition containing the same as an effective ingredient which has leukotriene C4 antagonistic action and leukotriene E4 antagonistic action in addition to potent leukotriene D4 antagonistic action, and useful as antiasthmatic agent, antiallergic agent and anti-inflammatory agent.

  本发明公开了一种由式（I）表示的二苯并环庚烯化合物： 其中 R1：氢原子、卤素原子等；R2：氢原子、卤素原子等；A：5 元或 6 元杂芳环基团，含有 1 至 3 个选自氮原子、氧原子和硫原子组成的杂原子，且该杂芳环基团等可具有卤素原子、氮原子等作为取代基；B：式中；-CH=CH-、式中；-CH2O-等、Y：C1-C10 亚烷基，可有卤素原子等作为取代基等，Z：羧基，可被保护等，m：1 至 4 的整数，n：1 至 3 的整数、 ------ 代表单键或双键、 或其药学上可接受的盐，以及以其为有效成分的医用组合物，该组合物除具有强效的白三烯 D4 拮抗作用外，还具有白三烯 C4 拮抗作用和白三烯 E4 拮抗作用，可用作抗哮喘剂、抗过敏剂和抗炎剂。
• US7309718B2
  申请人：——

  公开号：US7309718B2

  公开（公告）日：2007-12-18
• [EN] THIOTRIAZOLYL DERIVATIVES<br/>[FR] DERIVES DE THIOTRIAZOLYLE
  申请人：EPIX DELAWARE INC

  公开号：WO2007047394A2

  公开（公告）日：2007-04-26

  [EN] The invention relates to KvI.5 ion channel antagonists. Novel thiotriazolyl derivative compounds represented by Formula I, and synthesis and uses thereof for treating diseases mediated directly or indirectly by KvI.5 ion channels, are disclosed. Such conditions include numerous heart conditions including atrial fibrillation and other diseases; as well as epilepsy, anxiety, depression, age-related memory loss, migraine, obesity, Parkinson's disease or Alzheimer's disease. Methods of preparation and novel intermediates and pharmaceutical salts thereof are also provided.
  [FR] L'invention concerne des antagonistes des canaux ioniques Kv1.5. Elle concerne notamment de nouveaux dérivés de thiotriazolyle représentés par la formule (I) ainsi que la synthèse et les utilisations de ceux-ci pour traiter des maladies médiées directement ou indirectement par les canaux ioniques Kv1.5. Ces maladies incluent diverses affections cardiaques, telles que la fibrillation auriculaire et d'autres maladies, ainsi que l'épilepsie, l'anxiété, la dépression, la perte de mémoire liée à l'âge, la migraine, l'obésité, la maladie de Parkinson ou la maladie d'Alzheimer. L'invention concerne en outre des procédés de préparation ainsi que de nouveaux produits intermédiaires et des sels pharmaceutiques correspondants.
• Chemical and Pharmacological Properties of 3-(Thiophen-2-yl)-4-substituted-Δ²-1,2,4-triazoline-5-thiones
  作者：Agata Siwek、Monika Wujec、Maria Dobosz、Ewa Jagiełło-Wójtowicz、Agnieszka Kleinrok、Anna Chodkowska、Piotr Paneth

  DOI：10.1080/10426500801968136

  日期：2008.10.7

  Three 3-(thiophen-2-yl)-4-substituted-Delta(2)-1,2,4-triazoline-5-thiones were synthesized by intramolecular cyclization of 1-(thiophen-2-ylcarbonyl)-4-substituted thiosemicarbazides in alkaline medium. Their effects on the central nervous system (CNS) of mice in some behavioral tests were investigated. All investigated compounds displayed antinociceptive activity. The correlation between the structural features and bioactivity has been discussed.